Literature DB >> 1560198

Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes.

R R Caspi1, B G Grubbs, C C Chan, G J Chader, B Wiggert.   

Abstract

Experimental autoimmune uveoretinitis (EAU) in animals is a T cell-mediated autoimmune response directed against cells of the neural retina, in particular the photoreceptors. EAU can be induced in susceptible strains of mice by immunization with purified retinal Ag, and serves as a model for human uveitis. Because strong HLA associations have been noted in a number of human uveitic diseases, we investigated the role of MHC vs non-MHC genes in the control of susceptibility to ocular autoimmunity using the mouse EAU model. Selected strains representing most of the known independent H-2 haplotypes, as well as several H-2-recombinant and congenic strains, were immunized with interphotoreceptor retinoid-binding protein. Ocular pathology was induced in strains of the H-2k haplotype and their I-A-matched congenics, as well as in strains of the H-2r, H-2b, and H-2d haplotypes. In a series of experiments utilizing intra-H-2 recombinant strains, MHC control of susceptibility was tentatively mapped to the I-A subregion of the H-2k. Expression of the I-Ek gene product was not required for susceptibility to EAU, and in fact appeared to have an ameliorating effect on disease. Incidence and severity of disease obtained in strains sharing the same H-2 on a different background, or sharing the same background in the context of a different H-2, indicated that non-MHC genes contribute significantly to the regulation of EAU. Disease expression of susceptible H-2 haplotypes was highest in strains with B10 background (permissive) and ranged from intermediate to absent in strains with other (nonpermissive) backgrounds. The data suggest that although the ability to develop ocular pathology is dependent on the I-A subregion of the H-2, the final expression of disease in susceptible haplotypes is largely determined by background, non-MHC genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560198

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  Immune mechanisms in uveitis.

Authors:  R R Caspi
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Anterior uveitis: clinical and research perspectives.

Authors:  J T Rosenbaum; T M Martin; S R Planck
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.

Authors:  Rafael S Grajewski; Anna M Hansen; Rajeev K Agarwal; Mitchell Kronenberg; Stephane Sidobre; Shao Bo Su; Phyllis B Silver; Moriya Tsuji; Richard W Franck; Anne P Lawton; Chi-Chao Chan; Rachel R Caspi
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Understanding autoimmune uveitis through animal models. The Friedenwald Lecture.

Authors:  Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

5.  Rodent models of experimental autoimmune uveitis.

Authors:  Rajeev K Agarwal; Phyllis B Silver; Rachel R Caspi
Journal:  Methods Mol Biol       Date:  2012

6.  Interferon-γ regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis.

Authors:  Jelena M Kezic; Michael P Davey; Tibor T Glant; James T Rosenbaum; Holly L Rosenzweig
Journal:  Arthritis Rheum       Date:  2012-03

7.  Local activation of dendritic cells alters the pathogenesis of autoimmune disease in the retina.

Authors:  Neal D Heuss; Ute Lehmann; Christopher C Norbury; Scott W McPherson; Dale S Gregerson
Journal:  J Immunol       Date:  2012-01-04       Impact factor: 5.422

8.  Common genetic determinants of uveitis shared with other autoimmune disorders.

Authors:  Mary J Mattapallil; Azize Sahin; Phyllis B Silver; Shu-Hui Sun; Chi-Chao Chan; Elaine F Remmers; J Fielding Hejtmancik; Rachel R Caspi
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.

Authors:  Joanne Boldison; Tarnjit K Khera; David A Copland; Madeleine L Stimpson; Gemma L Crawford; Andrew D Dick; Lindsay B Nicholson
Journal:  Immunology       Date:  2015-08-11       Impact factor: 7.397

Review 10.  Regulation, counter-regulation, and immunotherapy of autoimmune responses to immunologically privileged retinal antigens.

Authors:  Rachel R Caspi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.